Movianto Germany was working with a global, leading European specialist pharmaceutical company that has brought transformative products to patients for decades. The products ranged from standard to high-value-low-volume products – mainly for intestinal health. Movianto had already been providing warehousing, distribution and value-added services to this company, mainly distributing to wholesalers and specialist clinics.
The customer’s production facilities were unable to deliver the planned volumes required by the market due to the coronavirus’s effect on supply chains in 2020. As a result, several of the client’s products were unavailable or out of stock for an unpredictable period of time, which meant that many of the necessary examinations at specialist clinics could not take place and patient’s care was delayed.